Compassionate use of cell products: [Letter to Editor]

Santis, Gil Cunha de; Ubiali, Eugênia Maria Amorim; Covas, Dimas Tadeu.
Rev. bras. hematol. hemoter ; 35(2): 144-145, 2013.
Artigo em Inglês | LILACS | ID: lil-676320

Documentos relacionados

  1. Considerations for the Use of Phage Therapy in Clinical Practice.
  2. An International Society for Cell & Gene Therapy working group short report on the future of expanded access to unapproved cell and gene therapies.
  3. Public availability of results of ClinicalTrials.gov-registered expanded access studies.
  4. Six-year activity on approval of compassionate use of medicines by the Ethics Committee of the University Hospital of Bologna (Italy): time to update rules and recommendations.
  5. Ethics review in compassionate use.
  6. Off-label and compassionate use of targeted anticancer therapies: The experience of an Italian pediatric cancer center.
  7. [Summary of the conference "Phages and phage therapy: from Félix d'Hérelle to 2.0 phages"].
  8. Oncology Expanded Access and FDA's Project Facilitate.
  9. Compassionate Use of REGEN-COV® in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody Disorders.
  10. Post-trial access to investigational drugs in India: addressing challenges in the regulatory framework.